Breaking News Instant updates and real-time market news.

TMH

TeamHealth

, AMSG

Bought by EVHC

$65.79

-0.47 (-0.71%)

09:28
10/05/16
10/05
09:28
10/05/16
09:28

TeamHealth possible sale helpful for the sector, says Stephens

Stephens analyst Dana Hambly says Dow Jones' report that TeamHealth (TMH) is in talks with private equity regarding a possible sale should not come as a complete surprise in the wake of the AmSurg (AMSG)/Envision Healthcare (EVHC) merger and depressed valuation. The analyst says the company may be worth $42-$57 per share, but notes that the upper end of the range suggests an uncomfortably high debt level which could be the deal's biggest barrier if the Board is not willing to "leave too much on the table." Nonetheless, Hambly views the news as helpful for the sector which may finally get a valuation floor. He reiterates an Overweight rating and $50 price target on TeamHealth's shares.

TMH

TeamHealth

AMSG

Bought by EVHC

$65.79

-0.47 (-0.71%)

EVHC

Envision Healthcare

  • 01

    Nov

  • 06

    Nov

TMH TeamHealth

08/25/16
LEER
08/25/16
NO CHANGE
Target $40
LEER
Outperform
TeamHealth price target lowered to $40 from $56 at Leerink
Leerink analyst Ana Gupte lowered her price target for TeamHealth to $40 from $56 after a weak Q2 and her meetings with the company's CEO Mike Snow and CFO David Jones. The analyst sees risks to 2016 EBITDA achievability given a quarter miss and guide-down, slower turnaround of IPC legacy business, and leverage ratio that could hamper M&A. Leerink has an Outperform rating on the shares.
09/09/16
STFL
09/09/16
NO CHANGE
STFL
TeamHealth weakness creates buying opportunity, says Stifel
Stifel analyst Chad Vanacore says that the large decline in TeamHealth's stock this year has left the shares looking undervalued and has created a buying opportunity. Vanacore is upbeat on the company's new CEO, and he continues to expect the company to benefit from current trends in the healthcare sector. He trimmed his price target on the stock to $43 from $48 but keeps a Buy rating.
09/26/16
SBSH
09/26/16
INITIATION
Target $36
SBSH
Neutral
TeamHealth initiated with a Neutral at Citi
Citi analyst Ralph Giacobbe started TeamHealth Holdings with a Neutral rating and $36 price target.
10/05/16
JEFF
10/05/16
NO CHANGE
Target $47
JEFF
Buy
TeamHealth can go private for $45-$58 per share, says Jefferies
Jefferies analyst Brian Tanquilut sees strategic rationale in TeamHealth going private and thinks the company can be worth $45-$58 per share in such a transaction. The stock closed yesterday up $5.40 to $38.20 after the Wall Street Journal reported that the company is exploring a sale to private-equity. Tanquilut believes TeamHealth is an interested seller after rejecting AmSurg's (AMSG) hostile takeover attempt last year and he sees strategic value in the asset. The analyst has a Buy rating on the shares with a $47 price target.
AMSG Bought by EVHC
$65.79

-0.47 (-0.71%)

06/17/16
OPCO
06/17/16
DOWNGRADE
OPCO
Perform
Envision Healthcare downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Michael Wiederhorn downgraded Envision Healthcare (EVHC) citing the company's merger agreement with AmSurg (AMSG).
09/26/16
SBSH
09/26/16
INITIATION
Target $79
SBSH
Buy
AmSurg initiated with a Buy at Citi
Citi analyst Ralph Giacobbe started AmSurg (AMSG) with a Buy rating and $79 price target. The pending merger with Envision Healthcare (EVHC) is as an attractive combination that should offer a strong growth profile over the foreseeable future, Giacobbe tells investors in a research note.
09/26/16
SBSH
09/26/16
UPGRADE
Target $26
SBSH
Buy
Envision Healthcare upgraded to Buy from Neutral at Citi
Citi analyst Ralph Giacobbe upgraded Envision Healthcare (EVHC) to Buy saying the pending merger with AmSurg (AMSG) should offer a strong growth profile over the foreseeable future. The analyst lowered his price target for the shares to $26 from $7.Giacobbe this morning also initiated shares of AmSurg with a Buy rating.
EVHC Envision Healthcare

06/16/16
BARD
06/16/16
NO CHANGE
BARD
Outperform
Baird says buy Envision Healthcare, Amsurg on weakness
Baird said they are positive on the deal agreed to by Envision Healthcare (EVHC) and AmSurg (AMSG) and recommend buying both on any weakness. The firm feels the synergy targets are too low, as both companies are growing faster apart than the projected rate together. Baird reiterated its Outperform ratings on both Envision and AmSurg shares.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

13:17
01/22/18
01/22
13:17
01/22/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
01/22/18
01/22
13:16
01/22/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JUNO

Juno Therapeutics

$67.81

-3.56 (-4.99%)

13:14
01/22/18
01/22
13:14
01/22/18
13:14
Downgrade
Juno Therapeutics rating change  »

Juno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$52.81

0.895 (1.72%)

, T

AT&T

$37.47

0.26 (0.70%)

13:14
01/22/18
01/22
13:14
01/22/18
13:14
Earnings
On The Fly: What to watch in telecom sector earnings reports »

Verizon (VZ) is scheduled…

VZ

Verizon

$52.81

0.895 (1.72%)

T

AT&T

$37.47

0.26 (0.70%)

S

Sprint

$5.32

-0.155 (-2.83%)

TMUS

T-Mobile

$63.71

0.83 (1.32%)

TWX

Time Warner

$93.65

0.29 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

  • 31

    Jan

  • 02

    Feb

  • 12

    Feb

SOGO

Sogou

$11.24

-0.203 (-1.77%)

13:10
01/22/18
01/22
13:10
01/22/18
13:10
Options
Call buyers sizing up Sogou and implied volatility reaches 52-week highs »

Call buyers sizing up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

SAP

SAP

$112.47

-0.73 (-0.64%)

13:02
01/22/18
01/22
13:02
01/22/18
13:02
Hot Stocks
SAP to invest over EUR2B in France over five years »

SAP CEO Bill McDermott…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

VZ

Verizon

$52.81

0.895 (1.72%)

13:00
01/22/18
01/22
13:00
01/22/18
13:00
Options
Bold pre-earnings play in Verizon »

Bold pre-earnings play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

EADSY

Airbus

$28.43

0.755 (2.73%)

, BA

Boeing

$340.46

2.7261 (0.81%)

12:56
01/22/18
01/22
12:56
01/22/18
12:56
Periodicals
Air Lease CEO: Airbus planning response to new Boeing jet, Reuters says »

Airbus (EADSY) intends to…

EADSY

Airbus

$28.43

0.755 (2.73%)

BA

Boeing

$340.46

2.7261 (0.81%)

AL

Air Lease

$49.02

0.31 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

  • 22

    Feb

ADP

ADP

$121.44

0.54 (0.45%)

, CSOD

Cornerstone OnDemand

$40.12

0.48 (1.21%)

12:55
01/22/18
01/22
12:55
01/22/18
12:55
Conference/Events
Stephens enterprise software analyst holds analyst/industry conference call »

Enterprise Software…

ADP

ADP

$121.44

0.54 (0.45%)

CSOD

Cornerstone OnDemand

$40.12

0.48 (1.21%)

MSFT

Microsoft

$90.00

-0.1 (-0.11%)

ORCL

Oracle

$50.48

-0.1 (-0.20%)

PAYC

Paycom

$92.03

0.84 (0.92%)

PCTY

Paylocity

$49.99

0.33 (0.66%)

SAP

SAP

$112.50

-0.7 (-0.62%)

ULTI

Ultimate Software

$227.99

-0.84 (-0.37%)

WDAY

Workday

$114.11

0.83 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 26

    Jan

  • 31

    Jan

  • 31

    Jan

  • 06

    Feb

  • 06

    Feb

  • 07

    Feb

  • 13

    Feb

  • 26

    Feb

  • 13

    Mar

  • 14

    Mar

HBI

Hanesbrands

$22.94

-0.26 (-1.12%)

12:50
01/22/18
01/22
12:50
01/22/18
12:50
Options
Hanesbrands puts and calls drawing interest Monday »

Hanesbrands puts and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$45.47

0.66 (1.47%)

12:45
01/22/18
01/22
12:45
01/22/18
12:45
Hot Stocks
Intel found root cause for Broadwell and Haswell platform issues »

Intel's Navin Shenoy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

QD

Qudian

$12.50

0.1 (0.81%)

12:45
01/22/18
01/22
12:45
01/22/18
12:45
Options
Qudian Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$44.82

0.34 (0.76%)

12:44
01/22/18
01/22
12:44
01/22/18
12:44
Hot Stocks
Breaking Hot Stocks news story on Intel »

Intel says made good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

INTC

Intel

$44.82

0.34 (0.76%)

12:43
01/22/18
01/22
12:43
01/22/18
12:43
Hot Stocks
Breaking Hot Stocks news story on Intel »

Intel recommends stopping…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

BAC

Bank of America

$31.76

0.04 (0.13%)

12:43
01/22/18
01/22
12:43
01/22/18
12:43
Periodicals
Bank of America eliminates remaining free-checking eBanking accounts, WSJ says »

Bank of America has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

MS

Morgan Stanley

$57.02

-0.44 (-0.77%)

12:38
01/22/18
01/22
12:38
01/22/18
12:38
Hot Stocks
Breaking Hot Stocks news story on Morgan Stanley »

Morgan Stanley says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAR

Avis Budget

$45.78

2.43 (5.61%)

12:35
01/22/18
01/22
12:35
01/22/18
12:35
Options
Avis Budget put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

$3.59

-0.01 (-0.28%)

12:30
01/22/18
01/22
12:30
01/22/18
12:30
Conference/Events
Akari Therapeutics management to meet with William Blair »

Group luncheon to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

12:25
01/22/18
01/22
12:25
01/22/18
12:25
Conference/Events
UBS REITs analyst holds an analyst/industry conference call »

REITs Analyst Yulico…

OMER

Omeros

$16.70

-0.02 (-0.12%)

12:24
01/22/18
01/22
12:24
01/22/18
12:24
Hot Stocks
Omeros off highs following cautious Twitter mention »

Shares of Omeros are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$281.54

1.125 (0.40%)

, SPX

S&P 500

12:21
01/22/18
01/22
12:21
01/22/18
12:21
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Schumer says deal reached…

SPY

SPDR S&P 500 ETF Trust

$281.54

1.125 (0.40%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$12.59

0.12 (0.96%)

12:20
01/22/18
01/22
12:20
01/22/18
12:20
Options
AMD attracts a bullish three-way spread before shares tick higher »

AMD attracts a bullish…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

BG

Bunge

$80.40

2.84 (3.66%)

, ADM

Archer Daniels

$42.21

1.2505 (3.05%)

12:19
01/22/18
01/22
12:19
01/22/18
12:19
Recommendations
Bunge, Archer Daniels, Glencore analyst commentary  »

Credit Suisse says Archer…

BG

Bunge

$80.40

2.84 (3.66%)

ADM

Archer Daniels

$42.21

1.2505 (3.05%)

GLNCY

Glencore

$11.29

-0.02 (-0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 14

    Feb

$NSD

NASDAQ Market Internals

12:17
01/22/18
01/22
12:17
01/22/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
01/22/18
01/22
12:16
01/22/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.